RenovoRx, Inc. Common Stock (RNXT) Stock Price

RNXTStock

$1.42+32.94%52W

Market Cap$64.08M

P/E—

PEG Ratio—

Div yield—

Beta0.77

RNXT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)13.85%

Price vs S&P 500 (4W)34.72%

VGM Score66.29

Book Value / Share (Quarterly)$0.25

P/TBV (Annual)1.17x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.25

Price vs S&P 500 (YTD)36.83%

Gross Margin (TTM)78.71%

Net Profit Margin (TTM)-823.98%

EPS (TTM)$-0.33

10-Day Avg Trading Volume0.60M

EPS Excl Extra (TTM)$-0.33

EPS (Annual)$-0.32

ROI (Annual)-205.98%

Gross Margin (Annual)70.88%

Cash / Share (Quarterly)$0.27

Revenue Growth QoQ (YoY)185.79%

ROA (Last FY)-137.96%

EBITD / Share (TTM)$-0.35

ROE (5Y Avg)-173.15%

Operating Margin (TTM)-864.27%

Cash Flow / Share (Annual)$-0.30

P/B Ratio5.04x

P/B Ratio (Quarterly)4.04x

Net Income / Employee (Annual)$-656,900

EV / Revenue (TTM)29.82x

Net Interest Coverage (TTM)-6.61x

ROA (TTM)-104.62%

EPS Incl Extra (Annual)$-0.32

Current Ratio (Annual)4.02x

Quick Ratio (Quarterly)6.69x

3-Month Avg Trading Volume0.32M

52-Week Price Return32.94%

Revenue / Employee (TTM)$87,600

Tangible BV / Share (Quarterly)$0.00

P/S Ratio (Annual)50.55x

Asset Turnover (Annual)0.14x

52-Week High$1.50

EPS Excl Extra (Annual)$-0.32

26-Week Price Return25.10%

Quick Ratio (Annual)3.76x

13-Week Price Return41.79%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)7.15x

Enterprise Value$44.40M

Asset Turnover (TTM)0.13x

Revenue / Employee (Annual)$66,100

Pretax Margin (Annual)-994.48%

Cash / Share (Annual)$0.19

3-Month Return Std Dev80.61%

Net Income / Employee (TTM)$-721,700

ROE (Last FY)-205.98%

Net Interest Coverage (Annual)-3.73x

EPS Basic Excl Extra (Annual)$-0.32

Receivables Turnover (TTM)5.71x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.33

ROI (TTM)-138.61%

P/S Ratio (TTM)38.12x

Revenue / Share (Annual)$0.03

Tangible BV / Share (Annual)$0.68

Price vs S&P 500 (52W)14.63%

Year-to-Date Return48.79%

5-Day Price Return6.84%

EPS Normalized (Annual)$-0.32

ROA (5Y Avg)-223.86%

Net Profit Margin (Annual)-994.48%

Month-to-Date Return30.44%

EBITD / Share (Annual)$-0.35

Operating Margin (Annual)-1113.98%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-173.15%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.33

P/TBV (Quarterly)1205.88x

P/B Ratio (Annual)5.68x

Pretax Margin (TTM)-823.98%

Book Value / Share (Annual)$0.15

Price vs S&P 500 (13W)38.99%

Beta0.77x

Revenue / Share (TTM)$0.04

ROE (TTM)-138.61%

52-Week Low$0.70

vGradeD

gGradeA

mGradeA

vgmGradeB

RNXT Earnings Surprise History

Q2 25-0.08est. -0.08

Q3 25-0.08est. -0.08

Q4 25-0.08est. -0.08

Q1 26-0.08est. -0.08

Q2 26-0.05est. -0.07

RNXT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.10

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
RNXTRenovoRx, Inc. Common Stock	D	A	A	$1.42
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About RenovoRx, Inc. Common Stock

RenovoRx is a clinical-stage biopharmaceutical company developing targeted combination cancer therapies. Its proprietary Trans-Arterial Micro-Perfusion platform delivers therapeutics directly to tumors to potentially enhance efficacy while reducing toxicities compared to systemic intravenous therapy.